Evodiamine induces tumor cell death through different pathways: apoptosis and necrosis
Ying Zhang1, Li-Jun Wu, Shin-Ichi Tashiro
1China-Japan Research Institute of Medical and Pharmaceutical Sciences; Shenyang Pharmaceutical University, Shenyang 110016, China.
Aim:
To study the different death pathways in human cervical cancer HeLa and melanoma A375-S2 cells initiated by evodiamine.
Methods:
Viability of evodiamine-induced HeLa and A375-S2 cells was measured by MTT assay. Apoptotic cells with condensed or fragmented nuclei were visualized by Hoechst 33258 staining. Nucleosomal DNA fragmentation was assayed by agarose gel electrophoresis. Proportion of cell death through apoptotic and necrotic pathways was determined by LDH activity-based cytotoxicity assays. Cell cycle distribution was observed by flow cytometry.
Results:
Evodiamine induced HeLa and A375-S2 cell death dose- and time-dependently. Caspase-3 and -8 were activated in apoptosis induced by evodiamine 15 micromol/L. However, over 24-h incubation of A375-S2 cells, evodiamine 15 micromol/L initiated necrosis related to p38 and ERK (extracellular signal-regulated kinases) activities. Evodiamine-induced HeLa cell death was preceded by an accumulation of cells at the G2/M phase of the cell cycle, but there was no significant effect of evodiamine on A375-S2 cell cycle.
Conclusion:
Evodiamine induces caspase-3,8-dependent apoptosis in HeLa cells which is related to G2/M arrest of the cell cycle. On the other hand, in A375-S2 cells, evodiamine initiates caspase-3,8-mediated apoptosis at early stages and the induction of MAPK-mediated necrosis at later stages of cell culture.
Insights
Evodiamine triggers apoptosis in HeLa cells via cell cycle arrest, but induces both apoptosis and necrosis in melanoma cells through different pathways. This study clarifies evodiamine
Area of Science:
- Pharmacology
- Cancer Biology
- Cell Death Pathways
Background:
- Evodiamine is a natural alkaloid with potential anti-cancer properties.
- Understanding its mechanism of action is crucial for therapeutic development.
- Cervical cancer (HeLa) and melanoma (A375-S2) cells represent distinct cancer types with different cellular responses.
Purpose of the Study:
- To investigate the distinct cell death pathways induced by evodiamine in human cervical cancer (HeLa) and melanoma (A375-S2) cells.
- To elucidate the molecular mechanisms underlying evodiamine's cytotoxic effects.
Main Methods:
- Cell viability was assessed using MTT assays.
- Apoptosis was visualized via Hoechst 33258 staining and DNA fragmentation analysis.
- Necrosis was quantified using lactate dehydrogenase (LDH) release assays.
- Cell cycle distribution was analyzed by flow cytometry.
- Protein activation (caspase-3, -8, p38, ERK) was implied in the results.
Main Results:
- Evodiamine induced dose- and time-dependent cell death in both HeLa and A375-S2 cells.
- In HeLa cells, evodiamine triggered apoptosis associated with G2/M cell cycle arrest and caspase-3/8 activation.
- In A375-S2 cells, evodiamine induced early caspase-3/8-mediated apoptosis and later MAPK (p38/ERK)-related necrosis.
Conclusions:
- Evodiamine exhibits differential effects on cell death pathways in HeLa and A375-S2 cells.
- HeLa cells undergo apoptosis linked to G2/M cell cycle arrest.
- A375-S2 cells experience a dual death pathway involving early apoptosis and later necrosis mediated by MAPK signaling.
Related Concept Videos
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Apoptosis
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become anucleated and die, but their...
Cytotoxic Edema: Pathophysiology


